1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. Y-MABS THERAPEUTICS INC
Y-Mabs Therapeutics Inc XNAS: YMAB

Y-Mabs Therapeutics Inc Live Share Price Today, Share Analysis and Chart

about

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

Read More
4.21 -0.01 (-0.24%)
145.3K
XNAS Volume

XNAS 08 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Y-Mabs Therapeutics Inc is on 11 Jul 2025 for the purpose of Y-mAbs Therapeutics Inc Annual General Meeting for 2025 See details
Low Financial Strength
22.2 / 100
Expensive Valuation
20.8 / 100
Technically Bearish
22.8 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Y-Mabs Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..